New Selenoderivatives as Antitumoral Agents

The document discussed the potential of selenium (Se) as a promising treatment for prostate cancer (PC), highlighting its ability to inhibit PC through multiple mechanisms. Despite the prevalence of PC and the availability of treatments like hormone ablation therapy, radiation, and surgery, these options did not offer a cure and had significant side effects. The document emphasized the importance of prevention strategies, including pharmacological and dietary interventions, to reduce PC morbidity and mortality. Selenium, as a micronutrient, emerged as a significant focus in clinical trials, showing promise in controlling the development of PC.